Yorktown Management & Research Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,200
Closed -$309K 254
2020
Q2
$309K Buy
+2,200
New +$321K 0.28% 173
2019
Q2
Sell
-8,400
Closed -$1.17M 328
2019
Q1
$1.17M Hold
8,400
0.38% 66
2018
Q4
$1.08M Hold
8,400
0.36% 72
2018
Q3
$1.16M Hold
8,400
0.34% 84
2018
Q2
$1.02M Hold
8,400
0.3% 93
2018
Q1
$1.08M Hold
8,400
0.32% 75
2017
Q4
$1.17M Sell
8,400
-2,000
-19% -$279K 0.34% 76
2017
Q3
$1.35M Hold
10,400
0.35% 47
2017
Q2
$1.38M Hold
10,400
0.44% 41
2017
Q1
$1.29M Hold
10,400
0.34% 65
2016
Q4
$1.2M Buy
+10,400
New +$1.2M 0.3% 63
2016
Q1
Sell
-21,100
Closed -$2.17M 387
2015
Q4
$2.17M Buy
21,100
+10,100
+92% +$1.02M 0.38% 84
2015
Q3
$1.03M Buy
+11,000
New +$1.06M 0.17% 168

Other funds holding JNJ

Yorktown Management & Research Company's JNJ Position: Q3 2020 in Review

Yorktown Management & Research Company sold out of Johnson & Johnson (JNJ) in Q3 2020, closing a stake of 2,200 shares — an estimated $309K sold.

Yorktown Management & Research Company first reported a position in JNJ in Q3 2015 and held it in 13 quarters. The position peaked at $2.17M in Q4 2015. 2,985 funds tracked by Wall St. Rank hold JNJ as of Q3 2020.

  • Yorktown Management & Research Company reported no remaining Johnson & Johnson position as of Q3 2020 after selling out during the quarter.
  • Yorktown Management & Research Company sold 2,200 Johnson & Johnson shares in Q3 2020, an estimated $309K.
  • Yorktown Management & Research Company first reported a position in Johnson & Johnson in Q3 2015 and held it in 13 quarters.
  • Yorktown Management & Research Company's Johnson & Johnson position peaked at $2.17M in Q4 2015.
  • 2,985 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2020.

Based on Yorktown Management & Research Company's 13F filing for Q3 2020, filed 6 Nov 2020.